Literature DB >> 23529518

Opioid use in chronic non-cancer pain--part 2: prescribing issues and alternatives.

Simon Holliday1, Chris Hayes, Adrian Dunlop.   

Abstract

BACKGROUND: Managing pain requires time and effort to attend to its biopsychosocial characteristics. This requires proper planning and a whole-of-practice approach.
OBJECTIVE: This article describes how to prepare your practice for quality chronic pain care, and details a non-judgemental and effective management approach, including the minimisation of opioid harms. DISCUSSION: It is helpful to have a consistent, whole-of-practice approach when a patient new to the practice presents with a compelling case for opioids. Assessing patients with chronic pain includes a full medical history and detailed examination according to a biopsychosocial approach and applying 'universal precautions' to make a misuse risk assessment. A management plan should consider a range of non-opioid modalities, with a focus on active rather than passive strategies. Integrated multidisciplinary pain services have been shown to improve pain and function outcomes for patients with complex chronic pain issues, but access is often limited. Time-limited opioid use is recommended with initial and regular monitoring, including pain and function scores, urine toxicology, compliance with regulatory surveillance systems and assessment for adverse reactions and drug related aberrant behaviours. When ceasing prescribing, opioids should be weaned slowly, except in response to violence or criminal activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529518

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

Review 1.  Dealing with drug-seeking behaviour.

Authors:  Jenny James
Journal:  Aust Prescr       Date:  2016-06-01

Review 2.  Opioid prescribing pitfalls: medicolegal and regulatory issues.

Authors:  Walid Jammal; Grace Gown
Journal:  Aust Prescr       Date:  2015-09-02

3.  General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing.

Authors:  Ruth White; Chris Hayes; Allison W Boyes; Simon Chiu; Christine L Paul
Journal:  J Pain Res       Date:  2019-01-22       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.